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Abstract
Background: The genital skin of males hosts a diversity of HPV genotypes and uncharacterized HPV genotypes.
Previously we demonstrated that a specific viral genotype was not identified in 14% of all genital specimens
(i.e., HPV unclassified specimens) using the Roche Linear Array method. Our goal was to identify and assess the
prevalence of individual HPV types among genital HPV unclassified specimens collected in the HIM Study
population, at enrollment, and examine associations with socio-demographic and behavioral characteristics.
Methods: Genital skin specimens of men that were considered unclassified (HPV PCR positive, no genotype specified)
at enrollment were typed by sequencing amplified PGMY09/11 products or cloning of PGMY/GP+ nested amplicons
followed by sequencing. PGMY/GP+ negative specimens were further analyzed using FAP primers. HPV type
classification was conducted through comparisons with sequences in the GenBank database.
Results: Readable nucleotide sequences were generated for the majority of previously unclassified specimens (66%),
including both characterized (77%) and yet uncharacterized (23%) HPV types. Of the characterized HPV types, most
(73%) were Beta [β]-HPVs, primarily from β-1 and β-2 species, followed by Alpha [α]-HPVs (20%). Smokers (current and
former) were significantly more likely to have an α-HPV infection, compared with any other genus; no other factors
were associated with specific HPV genera or specific β-HPV species.
Conclusions: Male genital skin harbor a large number of β-HPV types. Knowledge concerning the prevalence of the
diverse HPV types in the men genital is important to better understand the transmission of these viruses.
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Background
Human papillomaviruses (HPVs) are a diverse group of
circular double-strand DNA viruses of approximately
8.000pb. Persistent infection with high-risk HPV is not
only the major etiological factor for cervical cancer de-
velopment but also for a high proportion of tumors of
the vagina, vulva, penis, anal canal and oropharynx [1].
A novel papillomavirus is defined whenever the complete
L1 sequence of a viral genome differs by at least 10% from
that of all characterized types [2]. To date, more than 180
different HPV types have been fully sequenced and charac-
terized. The majority of HPVs comprise three genera:
Alpha [α]-, Beta [β]- and Gamma [γ]-papillomavirus.
α-HPV types have been predominantly isolated from
mucosal and genital lesions, and include the 13 viral types
classified as high-risk oncogenic (carcinogen type I) by the
World Health Organization due to their increased preva-
lence in cervical cancer. β- and γ-HPV types were mainly
isolated from the skin and for this reason have been
grouped together as cutaneous HPV. β-HPVs are addition-
ally divided into 6 different species including 45 HPV
types, of which β-1 and β-2 are the most diverse and
prevalent. Similarly, γ-HPVs are separated into 20 species,
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which together include 50 different HPV types. Partial
DNA sequence information originating from several stud-
ies points towards the existence of hundreds of putative
novel HPV types of the β- and γ-HPV genera [3,4]. Recent
data describe high prevalence of cutaneous HPV types at
body sites that are different from those in which they were
originally isolated [5-8].
During the last decade, there has been growing inter-
est in understanding HPV natural history and related
diseases among men. The HPV Infection in Men (HIM)
Study is an ongoing, prospective genital HPV natural
history study of over 4.000 men aged 18–70 years resid-
ing in Brazil (São Paulo), Mexico (Cuernavaca), and the
United States (USA; Tampa). In this study, over 66% of
men tested positive for HPV at their first study visit;
however, the viral type could not be identified in 14% of
the genital specimens using the Linear Array method
(i.e., HPV PCR positive, no genotype specified) [9]. Our
goal was to examine the prevalence of HPV types among
genital HPV unclassified specimens collected among HIM
Study participants at enrollment, and examine associations
with socio-demographic and behavioral characteristics.
Methods
Study population
Men were enrolled between 2005 and 2009 and reported
no prior diagnosis of genital warts or anogenital cancers,
and had no recent symptoms of or treatment for a sexu-
ally transmitted infection, including HIV/AIDS. Men
completed a pre-enrollment (baseline) visit, were en-
rolled on completion of their second (enrollment) visit
two weeks post-baseline, and subsequently followed ap-
proximately every six months for up to four years. De-
tails of the HIM Study cohort are described elsewhere
[10,11]. The present cross-sectional prevalence study
was conducted among the first 3,105 men who com-
pleted their enrollment visits between July 2005 and
December 2008. The IRD of the University of South
Florida, Tampa, USA, the Instituto Mexicano del Seguro
Social, and the Instituto de Salud Publica de Mexico,
Mexico, and the Centro de Referência e Treinamento
DST//Aids, Brazil, approved all study procedures, and all
participants provided written informed consent.
Genital specimen collection, DNA extraction, and
HPV detection
At each study visit, participants completed a risk factor
questionnaire and underwent a clinical examination of
the external genital skin. Exfoliated cells were obtained
from the coronal sulcus/glans penis, penile shaft, and
scrotum using Dacron swabs (Digene, Gaithersburg,
MD, USA), and these samples were further combined
and stored at −80°C. HPV DNA was extracted using the
QIAamp Media MDx Kit (Qiagen, Valencia, CA, USA).
Samples were PCR amplified using PGMY09/11 generic
primers and genotyped using the Roche Linear Array
(Roche Molecular Diagnostics, Alameda, CA, USA). This
technique allows testing for the presence of 37 α-HPV
types commonly detected at the cervix (high-risk: 16, 18,
31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68; low-risk: 6, 11,
26, 40, 42, 53, 54, 55, 61, 62, 64, 66, 67, 69, 70, 71, 72,
73, 81, 82, 82 subtype IS39, 83, 84, 89 [CP6108]) [12].
Samples that tested PCR-positive and Linear Array-
negative were considered unclassified and underwent
additional typing.
Typing of unclassified samples
Initially, purified DNAs were HPV genotyped by direct
sequencing of PGMY09/11 primers PCR amplimers or
cloning of these amplicons followed by sequencing.
Next, 1 μl of PGMY09/11 negative product was used in
a nested PCR using GP5+/6+ primers [13] and positive
samples were cloned and sequenced. Finally, nested
PGMY09/11-GP5+/6+ PCR negative samples were sub-
mitted to a novel amplification reaction employing
FAP59/64 primers [14], and amplimers were analyzed
solely by direct sequencing. All PCRs were performed
using AmpliTaq Gold polymerase (Perkin-Elmer, Foster
City, CA, USA). Before direct sequencing, PCR products
were purified using the EXO SAP-IT (GE Healthcare,
Buckinghamshire, UK). Sequencing reactions were per-
formed in an ABI 3130XL Genetic Analyzer (AB Applied
Biosystems, CA, USA) using the BigDye Terminator v3.1
Cycle Sequencing kit (AB Applied Biosystems, CA, USA).
Sequence identity was determined by comparison with the
BlastN database; sequences with identity scores higher than
90% within at least 200 bp were conclusively typed.
Statistical analysis
The prevalence and genotype-distribution of unclassified
genital HPV infections were estimated among all men
enrolled in the HIM Study before December 2008. Infec-
tions were considered HPV-negative, HPV-positive for a
characterized type, HPV-positive for an uncharacterized
type, or untyped (i.e., inconclusive). Characterized HPV
types were further classified according to genus and spe-
cies. Socio-demographic and behavioral risk factors
thought to be associated with presence of 1) a specific
genus (α-, β-, γ-, or other HPV types), and 2) a specific
β-HPV species were evaluated using exact Pearson chi-
square tests and Monte Carlo methods. All statistical
tests were two-sided and attained statistical significance
at α = 0.05. Analyses were performed using SAS version
9.3 (SAS Institute, Cary, NC, USA).
Results
Of the 3105 men enrolled in the HIM Study through
December 2008, 1126 (36.3%) were HPV negative at their
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Table 1 Characteristics of 404 participants from the HIM Study with unclassified HPV in the genital area at enrollment
Total n = 404 USA n = 165 Brazil n = 134 Mexico n = 105 P valuea
Characteristic n (%) n (%) n (%) n (%)
Age, years <.001
Median (range) 30 (18–70) 20 (18–70) 36 (18–70) 35 (18–67)
Mean (SD) 32.1 (12.5) 25.6 (11.5) 36.8 (11.0) 36.3 (11.4)
18–30 212 (52.5%) 131 (79.4%) 43 (32.1%) 38 (36.2%)
31–44 130 (32.2%) 21 (12.7%) 63 (47.0%) 46 (43.8%)
≥45 62 (15.3%) 13 (7.9%) 28 (20.9%) 21 (20.0%)
Race <.001
White 221 (54.7%) 127 (77%) 87 (64.9%) 7 (6.7%)
Black 48 (11.9%) 14 (8.5%) 34 (25.4%) 0 (0%)
Asian/Pacific Islander 10 (2.5%) 10 (6.1%) 0 (0%) 0 (0%)
Mixed race 122 (30.2%) 13 (7.9%) 12 (9.0%) 97 (92.4%)
Missing data 3 (0.7%) 1 (0.6%) 1 (0.7%) 1 (1.0%)
Ethnicity <.001
Non-Hispanic 254 (63.0%) 142 (86.1%) 112 (84.2%) 0 (0%)
Hispanic 149 (37.0%) 23 (13.9%) 21 (15.8%) 105 (100%)
Marital status <.001
Single 211 (52.2%) 139 (84.2%) 47 (35.1%) 25 (23.8%)
Married 131 (32.4%) 15 (9.1%) 56 (41.8%) 60 (57.1%)
Cohabitating 45 (11.1%) 4 (2.4%) 24 (17.9%) 17 (16.2%)
Divorced, separated, or widowed 17 (4.2%) 7 (4.2%) 7 (5.2%) 3 (2.9%)
Education, years <.001
<12 76 (18.9%) 0 (0%) 35 (26.3%) 41 (39.0%)
12 100 (24.8%) 30 (18.2%) 52 (39.1 18 (17.1%)
13–15 146 (36.2%) 110 (66.7%) 20 (15.0%) 16 (15.2%)
16 60 (14.9%) 16 (9.7%) 22 (16.5%) 22 (21.0%)
≥17 21 (5.2%) 9 (5.5%) 4 (3.0%) 8 (7.6%)
Circumcision <.001
No 229 (56.7%) 36 (21.8%) 111 (82.8%) 82 (78.1%)
Yes 175 (43.3%) 129 (78.2%) 23 (17.2%) 23 (21.9%)
Smoking status <.001
Never 266 (66.2%) 116 (70.7%) 97 (72.9%) 53 (50.5%)
Former 73 (18.2%) 19 (11.6%) 26 (19.5%) 28 (26.7%)
Current 63 (15.7%) 29 (17.7%) 10 (7.5%) 24 (22.9%)
Alcohol intake, drinks per month <.001
0 106 (27.0%) 29 (17.9%) 52 (41.3%) 25 (24.0%)
1–30 163 (41.6%) 53 (32.7%) 52 (41.3%) 58 (55.8%)
≥31 123 (31.4%) 80 (49.4%) 22 (17.5%) 21 (20.2%)
Sexual orientation 0.006
MSW 337 (89.2%) 145 (93.5%) 102 (81%) 90 (92.8%)
MSM 22 (5.8%) 7 (4.5%) 12 (9.5%) 3 (3.1%)
MSWM 19 (5.0%) 3 (1.9%) 12 (9.5%) 4 (4.1%)
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enrollment visit, 1572 (50.6%) had at least one of the
37 α-HPV types detected in the Linear Array assay,
and 407 (13.1%) had an unclassified HPV type detected.
Of the 407 samples with unclassified HPV at enrollment,
404 were available for additional characterization. These
include 165, 134, and 105 men from the USA, Brazil and
Mexico, respectively. Table 1 presents socio-demographic
characteristics of participants included in this analysis, by
country. Men with unclassified HPV were more likely to
be younger (18–30 years, 52.5%), white (54.7%), non-
Hispanic (63.0%), single (52.2%), uncircumcised (56.7%),
never smokers (66.2%), moderate drinkers (41.6 and men
who have sex with women (89.2%).
HPV type distribution of previously unclassified HPV
infections is shown in Table 2. HPV could not be ge-
notyped among 121 (30.0%) FAP59/64 PCR-positive
specimens; direct sequencing was inconclusive due to
overlapping peak patterns. Among 265 (65.6 specimens
with successful sequences, 60 (22.6%) were considered
uncharacterized; sequence comparison analysis showed
high identity to partial HPV nucleotide sequences in
GenBank without type designation at this time. Among the
other 205 (77.4%) specimens with already characterized
HPV types, 41 (20.0%) belonged to the α-HPV genus, 150
(73.2%) to the β-HPV genus, and 14 (6.8%) to the γ-HPV
genus. The distribution of HPV types for each genus was
similar across countries, though a higher proportion
of γ-HPV types were detected in Brazil and Mexico as
compared to the USA.
The genotype-specific distribution of characterized HPV
types is found in Figure 1. A total of 27 α-HPV types, 32
β-HPV types, and 14 γ-HPV types were detected. The
most common α-HPV types included HPV-2 and HPV-6
(2.0 4 each), the most common β-HPVs included HPV-107
(11.7%), HPV-38 (7.8%), HPV-120 (6.8%), and HPV-
17 (4.8%), and the most common γ-HPVs included
HPV-4, HPV-134 and HPV-147 (1.0%, 2 each).
Of the risk factors, only cigarette smoking was signifi-
cantly associated with detection of α-, β-, or γ-HPV
types (Table 3); smokers (current and former) were sig-
nificantly more likely to have an α-HPV infection, com-
pared with any other genus (p = 0.039). No other factors
were significantly associated with the detection of a spe-
cific HPV genus. Nevertheless, the prevalence of α-HPV
types was non-significantly highest among participants
living in the USA, and those aged 18–30 years, white, non-
Hispanic, single, circumcised, and reported ≥8 lifetime sex
partners. In contrast, the prevalence of β-HPV types was
equally as high among men who were single and married/
cohabitating, and highest among men who were uncircum-
cised and reported <8 lifetime sex partners. γ-HPV types
were more common in Brazil and Mexico than USA, and
among men who were married/cohabitating, uncircum-
cised, and reported <8 lifetime sex partners. Further, none
of the risk factors examined were significantly associated
with particular β-HPV species detection.
Discussion
Recently we reported our initial observations concerning
the broad distribution of β- and γ-HPV types in genital
Table 1 Characteristics of 404 participants from the HIM Study with unclassified HPV in the genital area at enrollment
(Continued)
Lifetime number of sex partners 0.003
0–2 132 (33.0%) 59 (36.2%) 40 (30.3%) 33 (31.4%)
3–7 118 (29.5%) 53 (32.5%) 25 (18.9%) 40 (38.1%)
8–19 90 (22.5%) 27 (16.6%) 40 (30.3%) 23 (21.9%)
≥20 60 (15.0%) 24 (14.7%) 27 (20.5%) 9 (8.6%)
Diagnosis of sexually transmitted infection, ever 0.003
No 344 (85.6%) 152 (92.7%) 107 (80.5%) 85 (81.0%)
Yes 58 (14.4%) 12 (7.3%) 26 (19.5%) 20 (19.0%)
MSW, men who have sex with women; MSM, men who have sex with men; MSWM, men who have sex with women and men. aPearson chi-square P value using
exact Monte Carlo methods.
Table 2 HPV type distribution of previously unclassified









n (%) n (%) n (%) n (%)
HPV-negative 18 (4.5) 5 (3.0) 7 (5.2) 6 (5.7)
inconclusive HPVa 121 (30.0) 45 (27.3) 48 (35.8) 28 (26.7)
Any HPV typeb 265 (65.6) 115 (69.7) 79 (59.0) 71 (67.6)
Uncharacterized HPV
type
60 (22.6) 30 (26.1) 15 (19.0) 15 (21.1)
Characterized HPV type 205 (77.4) 85 (73.9) 64 (81.0) 56 (78.9)
Alpha (α)-HPV 41 (20.0) 19 (22.4) 12 (18.8) 10 (17.9)
Beta (β)-HPV 150 (73.2) 63 (74.1) 46 (71.9) 41 (73.2)
Gamma (γ)-HPV 14 (6.8) 3 (3.5) 6 (9.4) 5 (8.9)
asequences could not be interpreted.
bCharacterized and uncharacterized types.
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specimens of men participating in the HIM Study at en-
rollment through three years of follow-up [8]. We then
analyzed the β-HPV type distribution in external genital
lesion (EGL) specimens and preceding normal genital
skin specimens among HIM participants who developed
external genital lesions [7]. In the present study, we ex-
pand our previous work by presenting viral sequence
characterization of all unclassified HPV genital speci-
mens at the time of participant enrollment and by evalu-
ating the association of HPV detection with participant
characteristics and sexual behavior. Some studies have
reported the presence of cutaneous HPV types in penile
carcinomas [15] and in cervical and penile condylomas
[16,17]. However, to our knowledge the HIM study is
unique in searching for cutaneous HPV in normal male
genital skin specimens.
Among the 404 samples analyzed, 4.5% were truly
HPV negative, i.e. PCR negative using any of the three
primers sets, suggesting that a small proportion of un-
classified HPV detection presumably represents spurious
amplification. In 30.0% of the specimens, unreadable
sequences were generated after direct sequencing of
FAP54/69 PCR products; among these the presence of
more than one HPV type is suspected [14]. This hypoth-
esis has been confirmed through sequencing of a num-
ber of clones from each sample whenever overlapping
peak patterns were observed and also by the Luminex
technology [7,8]. DNA from multiple cutaneous HPV
types has been commonly detected not only in the nor-
mal skin and cutaneous tumors [16,18,19] but also in
oral cavity specimens [5], and in the anogenital tract [8].
Together these data suggest that cutaneous HPV types
may be a commensal component of the microbiological
flora of the human skin [4,20-22]. We also observed that
nucleotide sequences of 60 specimens mostly consisted
of partial FAP59/64 sequences previously deposited in
the GenBank database [23,24], and were therefore con-
sidered uncharacterized HPV types. Currently, more
than 200 different putative HPV types are pending full
genome characterization, with the majority clustering
within the γ-HPV genus [3]. We detected several α-HPVs
that should have been identified with the Linear-array
genotyping test. These false-negative results are likely due
to low viral copy numbers which were detected on a differ-
ent PCR reaction followed by sequencing, a more sensitive
technical approach.
Overall, unclassified HPV detection in HIM partici-
pants was significantly associated with younger age,
white race, and non-Hispanic ethnicity. β-HPV types
were detected among individuals residing in three coun-
tries and with diverse habits; however, slight differences
in participant characteristics were demonstrated in men
with α-HPVs versus β-HPVs, though none of these dif-
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Figure 1 HPV type distribution by HPV genus and types among unclassified genital samples of the HIM study at enrollment. HPV types
and species are indicated along the x-axis (n = 205).
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Table 3 Factors associated with HPV infections by genus in the male genital area
Characteristic Total n = 265a Alpha n = 41 Beta n = 150 Gamma n = 14 Uncharacterized n = 60 P valueb
n (%) n (%) n (%) n (%) n (%)
Country 0.649
USA 115 (43.4) 19 (46.3) 63 (42.0) 3 (21.4) 30 (50.0)
Brazil 79 (29.8) 12 (29.3) 46 (30.7) 6 (42.9) 15 (25.0)
Mexico 71 (26.8) 10 (24.4) 41 (27.3) 5 (35.7) 15 (25.0)
Age, years 0.279
18–30 130 (49.1) 23 (56.1) 75 (50.0) 7 (50.0) 25 (41.7)
31–44 89 (33.6) 9 (22.0) 49 (32.7) 7 (50.0) 24 (40.0)
≥45 46 (17.4) 9 (22.0) 26 (17.3) 0 (0) 11 (18.3)
Race 0.492
White 146 (55.1) 21 (51.2) 81 (54.0) 6 (42.9) 38 (63.3)
Black 30 (11.3) 9 (22.0) 15 (10.0) 1 (7.1) 5 (8.3)
Asian/Pacific Islander 7 (2.6) 1 (2.4) 4 (2.7) 0 (0) 2 (3.3)
Mixed race 80 (30.2) 10 (24.4) 48 (32.0) 7 (50.0) 15 (25.0)
Missing data 2 (0.8) 0 (0) 2 (1.3) 0 (0) 0 (0)
Ethnicity 0.503
Non-Hispanic 168 (63.6) 29 (70.7) 90 (60.0) 8 (61.5) 41 (68.3)
Hispanic 96 (36.4) 12 (29.3) 60 (40.0) 5 (38.5) 19 (31.7)
Marital status 0.328
Single 132 (49.8) 26 (63.4) 72 (48.0) 4 (28.6) 30 (50.0)
Married or cohabitating 121 (45.7) 14 (34.1) 69 (46.0) 10 (71.4) 28 (46.7)
Divorced, separated, or widowed 12 (4.5) 1 (2.4) 9 (6.0) 0 (0) 2 (3.3)
Education, years 0.761
≤12 116 (43.9) 18 (43.9) 65 (43.3) 6 (46.2) 27 (45.0)
13–15 96 (36.4) 15 (36.6) 53 (35.3) 3 (23.1) 25 (41.7)
≥16 52 (19.7) 8 (19.5) 32 (21.3) 4 (30.8) 8 (13.3)
Circumcision 0.470
No 135 (50.9) 17 (41.5%) 77 (51.3) 9 (64.3) 32 (53.3)
Yes 130 (49.1) 24 (58.5%) 73 (48.7) 5 (35.7) 28 (46.7)
Smoking status 0.039
Never 177 (67.3) 23 (56.1) 100 (67.1) 12 (92.3) 42 (70.0)
Former 45 (17.1) 6 (14.6) 31 (20.8) 1 (7.7) 7 (11.7)
Current 41 (15.6) 12 (29.3) 18 (12.1) 0 (0) 11 (18.3)
Alcohol intake, drinks per month 0.532
0 67 (26.2) 8 (20.5) 38 (26.2) 5 (41.7) 16 (26.7)
1–30 109 (42.6) 17 (43.6) 66 (45.5) 5 (41.7) 21 (35.0)
≥31 80 (31.3) 14 (35.9) 41 (28.3) 2 (16.7) 23 (38.3)
Sexual orientation 0.761
MSW 223 (90.3) 31 (83.8) 125 (90.6) 13 (100) 54 (91.5)
MSM 13 (5.3) 3 (8.1) 7 (5.1) 0 (0) 3 (5.1)
MSWM 11 (4.5) 3 (8.1) 6 (4.3) 0 (0) 2 (3.4)
Lifetime number of sex partners 0.152
0–2 77 (29.5) 9 (22.0) 49 (33.1) 6 (46.2) 13 (22.0)
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α-HPV prevalence in the genital region of men from the
HIM study [25], β-HPV DNA detection was not signifi-
cantly associated with sexual behaviors, indicating that
viral types from this genus may not be transmitted sexu-
ally. The risk factor questionnaire completed by HIM
participants focuses mostly on penetrative sexual behav-
ior and lacks information on masturbation practices and
non-penetrative sexual activities, which may be helpful
in understanding the mechanism of transmission for this
group of viruses. It is plausible that direct hand-to-penis
contact may favor viral transmission of cutaneous HPV
to the genital area. In fact, evidence of hand transmis-
sion to the anogenital region has been reported for
α-HPV types [26]. Furthermore, α-HPVs have been de-
tected on fingers of women who are infected at the cervix
[27]. Nevertheless, the possibility remains that the detec-
tion of β-HPVs in male genitals may also represent depos-
ition of virions shed from other body sites with productive
infections.
HPV characterization of skin specimens from healthy
individuals and squamous cell carcinomas of the skin
(SCC) indicated that HPV types of β-2 species predomi-
nates in tumor samples [24]. In the present study, the
analysis of participant characteristics and sexual behavior
stratified by β-HPV species found no significant associa-
tions. As with all studies, there are limitations that could
influence the interpretation of the results obtained. This
study was conceived to identify HPV types that were
grouped together as unclassified HPV types at enroll-
ment in the HIM Study. For this reason, this analysis ex-
cluded specimens for which an HPV type was already
assigned by Linear Array, although these specimens may
have also harbored β- and γ-HPV types. Co-detection
with α- and β-HPV types was shown to be common in
the oral cavity [5] and in penile condylomas [28].
The role of HPV in the development of non-melanoma
skin cancer is not well defined. Furthermore, it is un-
known whether HPV DNA detected in healthy skin repre-
sents viral particles or superficial cells containing episomal
HPV genomes [29]. It has been suggested that skin in-
fected with β-HPV types harbor increased susceptibility
to ultraviolet radiation induced DNA damage, ultimately
resulting in skin cancer [30]. At present, it is consensus
that HPV-5 and HPV-8 are associated with benign and
malignant lesions of the cutaneous disease epidermodys-
plasia verruciformis [31]. Recent data show the presence
of β-HPV types in the oral cavity [5,32], cervical and
penile condylomas [17,33] and also in cervicovaginal cells
[6,34]. Nevertheless, at least for the oral cavity, only viral
transcripts of α-HPV were detected in non-malignant le-
sions and cancer co-harboring β- or γ-HPV DNA [35].
Most studies examining the role of HPV in the develop-
ment of male EGL have evaluated mucosal HPV types of
the α-HPV genus. We observed that β-HPV DNA is
prevalent in EGLs (61.1%) and that most viral DNAs are
detected on the normal genital skin before EGL develop-
ment [7]. At present it is unclear how β-HPV types may
influence lesion development in the genital region of men.
Although detection of cutaneous HPV types in the genital
region may simply reflect virions released from other parts
of the body once β- and γ-HPV are ubiquitous throughout
the body, a possible role for these viruses as co-factors in
the oncogenesis of penile cancer remains to be clarified.
Studies conducted prospectively in a larger number of pa-
tients will contribute to this knowledge.
Conclusions
Detection of HPV types not previously assigned by Roche´s
Linear-Array in the genitals of participants of a natural
history study of HPV in men was significantly associated
with younger age, white race, and non-Hispanic ethnicity.
Among these HPVs, we detected a broad range of α- and
β-HPVs. Further research is needed to determine how these
cutaneous HPV are transmitted.
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Ethical approval was given by the University of South
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Abbreviations
HPV: Human papillomavirus; HIM Study: HPV Infection in Men Study; β-HPV: beta-
HPV; α-HPV: alpha-HPV; γ-HPV: gamma-HPV.
Table 3 Factors associated with HPV infections by genus in the male genital area (Continued)
3–7 85 (32.6) 9 (22.0) 49 (33.1) 4 (30.8) 23 (39.0)
8–19 58 (22.2) 15 (36.6) 27 (18.2) 3 (23.1) 13 (22.0)
≥20 41 (15.7) 8 (19.5) 23 (15.5) 0 (0) 10 (16.9)
Diagnosis of sexually transmitted infection, ever 0.887
No 230 (87.5) 35 (85.4) 131 (87.3) 11 (84.6) 53 (89.8)
Yes 33 (12.5) 6 (14.6) 19 (12.7) 2 (15.4) 6 (10.2)
aTotal number of men with characterized (α-, β- or γ-HPV) or uncharacterized HPV types.
bPearson chi-square P value using exact Monte Carlo methods.
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